7-1022730-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001318252.2(CHLSN):​c.130-12587A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 152,066 control chromosomes in the GnomAD database, including 3,116 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3116 hom., cov: 33)

Consequence

CHLSN
NM_001318252.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.852

Publications

13 publications found
Variant links:
Genes affected
CHLSN (HGNC:22421): (chromosome 7 open reading frame 50) Enables RNA binding activity. [provided by Alliance of Genome Resources, Apr 2022]
MIR339 (HGNC:31776): (microRNA 339) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.231 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001318252.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHLSN
NM_001318252.2
MANE Select
c.130-12587A>G
intron
N/ANP_001305181.1
CHLSN
NM_001424325.1
c.130-12587A>G
intron
N/ANP_001411254.1
CHLSN
NM_001424326.1
c.130-12587A>G
intron
N/ANP_001411255.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C7orf50
ENST00000397098.8
TSL:1 MANE Select
c.130-12587A>G
intron
N/AENSP00000380286.3
C7orf50
ENST00000357429.10
TSL:1
c.130-12587A>G
intron
N/AENSP00000350011.5
C7orf50
ENST00000397100.6
TSL:3
c.130-12587A>G
intron
N/AENSP00000380288.2

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29819
AN:
151948
Hom.:
3112
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.176
Gnomad AMR
AF:
0.237
Gnomad ASJ
AF:
0.141
Gnomad EAS
AF:
0.132
Gnomad SAS
AF:
0.148
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.197
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.196
AC:
29838
AN:
152066
Hom.:
3116
Cov.:
33
AF XY:
0.197
AC XY:
14617
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.161
AC:
6676
AN:
41480
American (AMR)
AF:
0.237
AC:
3626
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
489
AN:
3470
East Asian (EAS)
AF:
0.132
AC:
681
AN:
5174
South Asian (SAS)
AF:
0.148
AC:
712
AN:
4818
European-Finnish (FIN)
AF:
0.265
AC:
2797
AN:
10572
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.210
AC:
14248
AN:
67958
Other (OTH)
AF:
0.194
AC:
409
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1239
2479
3718
4958
6197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
1609
Bravo
AF:
0.193
Asia WGS
AF:
0.136
AC:
472
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.91
DANN
Benign
0.62
PhyloP100
-0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057558; hg19: chr7-1062366; API